(Q45113360)

9 December 2017

Treatment of fulminant hepatic failure with intravenous prostaglandin E1. (English)

1 reference

9 December 2017

Sterling RK

1

1 reference

9 December 2017

Luketic VA

series ordinal

2

1 reference

9 December 2017

Sanyal AJ

series ordinal

3

1 reference

9 December 2017

Shiffman ML

series ordinal

4

1 reference

9 December 2017

1 September 1998

1 reference

9 December 2017

Liver Transplantation

1 reference

9 December 2017

4

1 reference

9 December 2017

424-431

1 reference

9 December 2017

5

1 reference

Fulminant hepatic failure. Clinical features, etiology, epidemiology, and current management

9 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

Treatment of fulminant hepatic failure with insulin and glucagon. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

Liver cytoprotection by prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

Attenuation of acetaminophen hepatitis by prostaglandin E2. A histopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

Fulminant and subfulminant liver failure: definitions and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

Clinical experience with charcoal and resin hemoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500040501

21 January 2018

Identifiers

DOI

10.1002/LT.500040501

1 reference

9 December 2017

1 reference